## Abstract The present study focused on the involvement of γ‐aminobutyric acid transporter I (GAT1) in pain. We found that GABA uptake was increased in mouse spinal cord at 20 min and 120 min after formalin injection and in mouse brain at 120 min, but not 20 min, after formalin injection. In addit
Decrease of morphine-induced reward effects and withdrawal symptoms in mice overexpressing γ-aminobutyric acid transporter I
✍ Scribed by Jia-Hua Hu; Na Yang; Ying-Hua Ma; Xiao-Gang Zhou; Xu-Ying Zhang; Jie Jiang; Zhen-Tong Mei; Jian Fei; Li-He Guo
- Publisher
- John Wiley and Sons
- Year
- 2003
- Tongue
- English
- Weight
- 232 KB
- Volume
- 74
- Category
- Article
- ISSN
- 0360-4012
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Morphine addiction has been shown to result from neural adaptations produced by repeated drug exposure, but the mechanism is still unclear. In the present study, we found that γ‐aminobutyric acid (GABA) uptake was increased in mouse brain 120 min after, but not 20 min after, morphine (10 mg/kg, s.c.) injection. We generated GABA transporter I (GAT1)‐overexpressing mice to investigate whether the GABAergic system and GABA transporter are involved in morphine‐induced reward effects and withdrawal symptoms. Our results revealed that the rewarding effects induced by morphine were significantly decreased in GAT1‐overexpressing mice as measured by the conditioned place preference (CPP) paradigm. Moreover, both somatic and vegetative signs of naloxone‐induced morphine withdrawal symptoms were substantially reduced in GAT1‐overexpressing mice. In addition, the decreased morphine rewarding in transgenic mice could be recovered when mice were coinjected with NO‐711 (a GAT1 selective inhibitor) in the CPP paradigm. These findings suggest that the GABAergic system plays an important role in morphine addiction and point to the possibility of developing drugs that target GAT1 and extend the clinical application of opiates. © 2003 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES